Immediate adverse events to intravenous immunoglobulin in pediatric patients with inborn errors of immunity: A longitudinal study with a pre-infusion protocol

Immediate adverse events to intravenous immunoglobulin in pediatric patients with inborn errors of immunity: A longitudinal study with a pre-infusion protocol

Introduction: Immunoglobulin represents the main therapy for patients with inborn errors of immunity (IEI) and it is a safe procedure, but adverse events (AEs) can occur with variable frequencies. Objective: To evaluate the frequency of immediate AEs to intravenous immunoglobulin (IVIG) regular ther...

Full description

Bibliographic Details
Main Authors: Thales Silva Antunes, Karina Mescouto Melo, Cláudia França Cavalcante Valente, Fabíola Scancetti Tavares
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Immunoglobulin
Primary immunodeficiency
Inborn errors of immunity
Adverse events
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137922000979

Internet

http://www.sciencedirect.com/science/article/pii/S2531137922000979

Similar Items